Literature DB >> 28024184

Serpinb9 is a marker of antigen cross-presenting dendritic cells.

M S Mangan1, J Vega-Ramos2, L T Joeckel1, A J Mitchell3, A Rizzitelli1, B Roediger3, D Kaiserman1, W W Weninger4, J A Villadangos5, P I Bird6.   

Abstract

Serpinb9 (Sb9, also called Spi6) is an intracellular inhibitor of granzyme B (grB) that protects cytotoxic lymphocytes from grB-mediated death. In addition, Sb9 is also expressed in accessory immune cells, including dendritic cells (DCs), although its role is debated. Recently, we have demonstrated that Sb9 plays a grB-independent role in cross-presentation of antigens by CD8+ DCs. Here, using a mouse line expressing green fluorescent protein knocked in under the control of the Sb9 promoter, we demonstrate that Sb9 expression is highest in those tissue-resident and migratory DC subsets capable of cross-presentation. Further, we show that CD8+ DCs can be divided into two subsets based on Sb9 expression, and that only the subset expressing higher levels of Sb9 is capable of cross-presentation. These findings add support for role for Sb9 cross-presentation, and indicate that high Sb9 expression is a novel marker of cross-presentation capable DCs.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cross-presentation; DCs; Dendritic cell; Granzyme B; SPI6; Serpinb9

Mesh:

Substances:

Year:  2016        PMID: 28024184     DOI: 10.1016/j.molimm.2016.12.011

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

Review 1.  Regulation of the Cell Biology of Antigen Cross-Presentation.

Authors:  J Magarian Blander
Journal:  Annu Rev Immunol       Date:  2018-02-28       Impact factor: 28.527

2.  ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection.

Authors:  Mohammad Arabpour; Cristina Lebrero-Fernandez; Karin Schön; Anneli Strömberg; Vanja Börjesson; Katharina Lahl; Marlies Ballegeer; Xavier Saelens; Davide Angeletti; William Agace; Nils Lycke
Journal:  Mucosal Immunol       Date:  2022-04-13       Impact factor: 8.701

3.  Dual Host-Intracellular Parasite Transcriptome of Enucleated Cells Hosting Leishmania amazonensis: Control of Half-Life of Host Cell Transcripts by the Parasite.

Authors:  Cristina M Orikaza; Carina C Pessoa; Fernanda V Paladino; Pilar T V Florentino; Clara L Barbiéri; Hiro Goto; Eduardo Milton Ramos-Sanchez; José Franco da Silveira; Michel Rabinovitch; Renato A Mortara; Fernando Real
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

4.  Type I IFN protects cancer cells from CD8+ T cell-mediated cytotoxicity after radiation.

Authors:  Jianzhou Chen; Yunhong Cao; Bostjan Markelc; Jakob Kaeppler; Jenny Af Vermeer; Ruth J Muschel
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

5.  Telomere length correlates with subtelomeric DNA methylation in long-term mindfulness practitioners.

Authors:  Maite Mendioroz; Marta Puebla-Guedea; Jesús Montero-Marín; Amaya Urdánoz-Casado; Idoia Blanco-Luquin; Miren Roldán; Alberto Labarga; Javier García-Campayo
Journal:  Sci Rep       Date:  2020-03-12       Impact factor: 4.379

Review 6.  Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment.

Authors:  Peijie Wu; Wei Gao; Miao Su; Edouard C Nice; Wenhui Zhang; Jie Lin; Na Xie
Journal:  Front Cell Dev Biol       Date:  2021-03-01

7.  The impact of cesarean delivery on infant DNA methylation.

Authors:  Qian Chen; Yanhong Ming; Yuexin Gan; Lisu Huang; Yanjun Zhao; Xia Wang; Yongjie Liu; Jun Zhang
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-30       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.